SBC Medical Group Holdings Incorporated Unrealized Gain (Loss) on Derivatives
SBC Medical Group Holdings Incorporated (SBC) reported Unrealized Gain (Loss) on Derivatives of $86.15 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2024-11-13
- SBC Medical Group Holdings Incorporated unrealized gain (loss) on derivatives for the quarter ending 2023-06-30 was $86.15K.
- SBC Medical Group Holdings Incorporated unrealized gain (loss) on derivatives for the quarter ending 2023-03-31 was $15.57K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month |
|---|---|---|
| 2023-06-30 | $86.15K 10-Q · filed 2024-11-13 | $101.72K derived: sum of 2 quarters · filed 2024-11-13 |
| 2023-03-31 | $15.57K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |